Advances in Hematological Malignancies
Recent decades have witnessed remarkable advancements in the area of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and gene editing are altering the survival rates for patients with blood cancers. Research studies continue to explore these innovative techniques, offering promise for more successful treatment